Experiences and perspectives on the GIST patient journey
Nancy Macdonald1, Ari Shapiro1, Christina Bender2, Marc Paolantonio2, John Coombs21Flince Research + Design, New York, NY, 2Novartis Pharmaceuticals, East Hanover, NJ, USAPurpose: The tyrosine kinase inhibitor (TKI) imatinib has improved outcomes for patients with unresectable or metastatic gastroin...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/experiences-and-perspectives-on-the-gist-patient-journey-a9556 |